Arbutus Presents New Data on AB-729, AB-836 and AB-101 at
AB-729, our RNAi therapeutic, provided robust and comparable HBsAg declines in both HBeAg+ and HBeAg- patients...
Source: globenewswire.com
Stay updated with breaking news from Data Poster. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AB-729, our RNAi therapeutic, provided robust and comparable HBsAg declines in both HBeAg+ and HBeAg- patients...